MedPath

Investigating the effect of Sambucus ebulus on hand eczema

Phase 3
Recruiting
Conditions
Hand eczema.
Dermatitis and eczema
L20-L30
Registration Number
IRCT20170930036486N2
Lead Sponsor
Babol University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
72
Inclusion Criteria

Age 18 to 60 years
Patients with hands eczema who have not received any topical medication from the 14 days prior to study

Exclusion Criteria

Pregnant mothers
Nursing mothers
The presence of underlying diseases of the kidney, liver, heart, diabetes,
History of drug allergy
Patients with obsessive-compulsive disorder or other mental illness that interferes with the study
Use of Systemic Corticosteroids or Immunosupressives over the past 4 weeks
Localized infection in the place of eczema

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of hand eczema. Timepoint: Before the intervention begins? 14? 28? 42th day after starting of treatment. Method of measurement: Hand eczema severity index.;Dermatology Life Quality Index. Timepoint: Before the intervention begins? 14? 28? 42th day after starting of treatment. Method of measurement: Dermatology Life Quality Index questionnaire.
Secondary Outcome Measures
NameTimeMethod
Rate of healing. Timepoint: Before the intervention begins? 14? 28? 42th day after starting of treatment. Method of measurement: Hand eczema severity index.
© Copyright 2025. All Rights Reserved by MedPath